Patient Monitoring Devices Market Report Scope & Overview:
Get More Information on Patient Monitoring Devices Market - Request Sample Report
The Patient Monitoring Devices Market was valued at USD 48.03 billion in 2023 and is expected to grow to USD 93.53 billion by 2032 and grow at a CAGR of 7.71% over the forecast period of 2024-2032.
Growing prevalence of diagnostic and monitoring devices for measuring, recording as well displaying biometric data from blood pressure, temperature to the detection status with a need in demand escalates market growth Shifting hospital care to homecare environments is a move designed in order to cut cost of treatment and it is getting common now. The COVID-19 pandemic has accelerated the utilization of remote patient monitoring devices, showing their value in providing more accessible and cost-effective care. Not only has it significantly increased the adoption of remote patient monitoring, thus supporting continuous health tracking beyond clinical settings and generating new revenue opportunities for healthcare providers while decreasing overall costs.
Chronic diseases are becoming increasingly common worldwide, which is driving the market for patient monitoring devices. The World Health Organization (WHO) reports that chronic diseases kill almost 73 % of the global deaths and cause roughly 60% burden in disease. Chronic diseases such as cardiovascular disease, chronic obstructive pulmonary disease (COPD), cancer and type II diabetes. However, by 2024 nearly 1.5 billion people live with at least one chronic disease while cardiovascular diseases are the leading cause of death worldwide affecting an estimated $520 million people globally. The diabetes affects such 537 million adults and then there are the chronic respiratory diseases spread among approximately 545 million people. A increasing number of these diseases result to growing requirement for patient monitoring devices.
Advanced monitoring systems are essential as healthcare organizations transition from ad-hoc to continuous monitoring to provide accurate data for treatment decisions. The devices are advanced technologically to help clinicians manage patients with chronic diseases, and ultimately improve care quality, reduce readmission rates and lower costs. Patient monitoring device is expected to have a market share growth as incidence of chronic disease increases and more need for regular assessment.
Drivers
Increasing rates of chronic conditions such as cardiovascular diseases, diabetes, and respiratory disorders drive demand for continuous monitoring solutions.
Innovations in sensor technology, wireless communication, and integration of multiple monitoring parameters into compact devices enhance the functionality and appeal of patient monitoring systems.
The expanding elderly population requires regular health monitoring, boosting the demand for patient monitoring devices for managing age-related health issues.
The trend toward home-based care and remote patient monitoring reduces healthcare costs and increases convenience, driving the adoption of portable and user-friendly monitoring devices.
One of the major factors driving this market is growing incidence rate of chronic diseases in critical care patients. With diseases such as cardiovascular related, diabetes and respiratory issues on the rise across world we need to continuously monitor our health. The World Health Organization (WHO) reports that 73% of global deaths and 60% of the global disease burden are due to chronic diseases as of last year. Cardiovascular diseases account for around 18 million deaths in a year and are the number one cause of death globally. In the United States continue to feel an increasing burden of chronic disease on their shoulders as illustrated by data collected and compiled by the Center for Disease Control (CDC), 6.2 million adults in the U.S. have heart failure according to data from CDC, and diabetes remains on an upward trajectory with approximately 37.3 million individuals affected as of 2022. This high prevalence of chronic diseases drives the demand for patient monitoring devices, as these devices are crucial for managing and tracking the progression of such conditions.
The chronic diseases necessitate regular monitoring and long-term management, which further emphasizes the need for advanced patient-monitoring solutions. The integration of these devices into routine health practices is a good way to detect diseases early, manage them on an ongoing basis and alert timely intervention which transitionally stabilizes the patient outcomes and quality of life.
Restraints
The high price of sophisticated monitoring systems can be a barrier for adoption, particularly in developing regions and among smaller healthcare facilities.
Strict regulatory requirements and lengthy approval processes can delay the introduction of new devices to the market and increase development costs.
Technical issues, such as device malfunctions or calibration errors, and the costs associated with maintaining and upgrading monitoring systems can impact market growth.
The regulatory and compliance landscape for patient monitoring devices could be complicated and restrictive in nature which may hamper market growth. For example, the U.S. Food and Drug Administration (FDA) has very stringent regulations on medical device approval which includes extensive clinical testing documentation & quality control measures The FDA notes that the approval of a new medical device may require several months to even years, based on how it is classified and whose level of risk. According to the FDA's guidance on medical device regulations, establishing rigorous conditions of safety and efficacy is a prerequisite for protecting patient health FDA, "Medical Devices". This is similarly true in the European Union, where compliance with Medical Device Regulation (MDR) and a legal process will create another veil of checks to assure product integrity that can be impeded further by additional documentation demands as required by any focused audit regime which may occur from enactment till eventual legislation closure date in addition to this new EU-logical implantation. These challenges are known to slow down the product launch, raise development costs and act as a barrier for market entry or even expansion.
By Product
The multi-parameter patient monitoring devices segment captured the significant revenue share 21% in 2023 of global market. They have these benefits because they operate on batteries, are cheap to implement, and the silicon systems used are very integrated combining many parameters into one compact low power solution. These recent developments can be integrated in a single chip, containing computing units and Bluetooth low-energy radios as well as ECG, respiration and pulse oximetry all along with the same circuit leading to efficient multi-parameters devices at an affordable price. This is changing as they become more important, not just in hospitals but also home care situations that are used to help diagnose a patient before being transported to an hospital and monitor the patient’s compliance with caregiver instructions.
Cardiology segment projected to grow with significant CAGR. The diagnosis and management of these heart diseases as well as cardiovascular system, Monitoring devices play a important role. This increased prevalence of cardiovascular diseases and number of cardiac surgeries is expected to drive the growth in this market. In United States 6.2 million adults have heart failure each year and thousands of people undergo cardiac surgery. With doctors, regularly tracking for complications and keeping an eye on the recovery is critically important after surgery. This should strengthen the growth of this sector and more, with an increase in cardiac monitoring technology such as GE Healthcare's Portrait Mobile along with the acquisition of Preventice Solutions by Boston Scientific Corporation.
By End use
The Hospitals dominates the monitoring devices market, and accounted revenue share of over 49.6% in 2023. The need for fast and accurate disease detection among hospitals, coupled with the rising volume of medical procedures drives this dominance. Growth in this sector is fuelled by increase in the number of patient admissions related to injuries, chronic diseases and other ailments. Monitors with multiple parameters are used to monitor vital signs such as oxygen saturation, respiration rate, blood pressure and heart in general wards and intensive care units.
It is anticipated that the home care industry will grow significantly in the upcoming years. These devices, which are to be used at home or within the hospital bedside environment include portable, adaptive and accurate therapeutic, diagnostic as well as monitoring agents. The home care is becoming mainstream part of patient monitoring devices market and as the focus shifts to deliver healthcare at home, development of these next-generation device becomes faster.
Need any customization research on Patient Monitoring Devices Market - Enquiry Now
Regional analysis
North America was the leading market in 2023, accounted for over 40% revenue share. The growth of the market in this region is driven primarily by factors such as accessible large chronic patient group, development & expansion of healthcare infrastructure; significant advances are being achieved for wireless and portable devices compatible with smart gadgets aimed to reduce out-of-pocket expenditure. Key players, including GE Healthcare, Edwards Lifesciences, Masimo Corporation and Natus Medical are investing heavily in research to improve patient monitoring technologies also adds up market value. An aging population, increasing rates of chronic disease prevalence and the ability to access wireless or portable components along with complex reimbursement schemes that reduce patient cost. As an example, a study from the Public Health Agency of Canada found that seniors report high prevalence rates for ischemic heart disease and chronich obstructive pulmonary disorder. The Canadian Chronic Disease Surveillance System also estimated that close to 6.3 million adults aged 65 and older would live with chronic diseases in future. In the U.S., significant market growth is anticipated due to new product launches and approvals. Specifically, Abbott launched the insertable cardiac monitor Jot Dx in July 2021 and Sleepiz' named device Sleepiz One+ cleared by FDA in age of july 2022. It is anticipated that these advancements will fuel the growth of the market.
The Asia Pacific region reportedly shows significant growth on the grounds of sedentary lifestyle checked with growing chronic diseases such as obesity and diabetes. The large diabetic populations in China and India are helping fuel market growth due, at least partially to greater levels of awareness on diabetes prevention.
The Major players are Smiths Medical, Biotronik, Mindray Medical International Ltd., Koninklijke Philips N.V., Nihon Kohden, Welch Allyn, Health anywhere Inc., Intel, GE Healthcare, Medtronic, Bosch, MASIMO CORPORATION, and others players
Recent Developments
GE HealthCare’s CARESCAPE Canvas Patient Monitoring Platform secured clearance from the FDA in April 2023. Together with CARESCAPE ONE, the platform will allow for a modular system that can scale up monitoring features to match the severity of each patient's status.
In Jan 2023, Senet and Telli Health Introduce First LoRaWAN-based Remote Patient Monitoring Hardware It enables access to healthcare in distant places and regions with scarce resources, such as indigenous communities whose health inequalities can be reduced by the implementation of this type of technology opening the scenario for future smart home services.
In June 2022, Abbott received approval from the FDA for its FreeStyle Libre 2 (iCGM) device in adults and children with diabetes throughout the United States. It monitors blood sugar levels every minute and gives real-time alarms to help diabetics keep an eye on their glucose levels.
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (Top 3 medical equipment manufacturer in the world) launched wearable patient monitor- mWear In May,2022. The unit has two configurations wearable mode (home monitoring mode) and continuous mode with indication lights showing carers the patient is ok in accordance with custom parameters set.
| Report Attributes | Details |
|---|---|
| Market Size in 2023 | USD 48.3 Billion |
| Market Size by 2032 | USD 93.53 Billion |
| CAGR | CAGR of 7.71% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Product (Blood Glucose Monitoring Systems, Cardiac Monitoring Devices, Multi-parameter Monitoring Devices., Respiratory Monitoring Devices, Temperature Monitoring Devices, Hemodynamic/Pressure Monitoring Devices, Fetal & Neonatal Monitoring Devices, Weight Monitoring Devices, Other Patient Monitoring Devices) • By End-use (Hospitals, Ambulatory Surgery Centers, Home Care Settings, Other) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe [Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
| Company Profiles | Smiths Medical, Biotronik, Mindray Medical International Ltd., Koninklijke Philips N.V., Nihon Kohden, Welch Allyn, Health anywhere Inc., Intel, GE Healthcare, Medtronic, Bosch, MASIMO CORPORATION |
| Key Drivers | • Increasing rates of chronic conditions such as cardiovascular diseases, diabetes, and respiratory disorders drive demand for continuous monitoring solutions. • Innovations in sensor technology, wireless communication, and integration of multiple monitoring parameters into compact devices enhance the functionality and appeal of patient monitoring systems. |
| RESTRAINTS | • The high price of sophisticated monitoring systems can be a barrier for adoption, particularly in developing regions and among smaller healthcare facilities. |
Ans. The projected market size for the Patient Monitoring Devices Market is USD 93.53 billion by 2032.
Ans: The Hospitals end user segment dominated the Patient Monitoring Devices Market.
Ans. The CAGR of the Patient Monitoring Devices Market is 7.71% During the forecast period of 2024-2032.
Ans: The North American region dominated the market in 2023, with a 40% share.
Ans: Yes, you can customize the report as per your requirements.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.2 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Incidence and Prevalence (2023)
5.2 Prescription Trends, (2023), by Region
5.3 Device Volume, by Region (2020-2032)
5.4 Healthcare Spending, by Region, (Government, Commercial, Private, Out-of-Pocket), 2023
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Product Benchmarking
6.3.1 Product specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and supply chain strategies
6.4.3 Expansion plans and new product launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Patient Monitoring Devices Market Segmentation, by Product
7.1 Chapter Overview
7.2 Blood Glucose Monitoring Systems
7.2.1 Blood Glucose Monitoring Systems Market Trends Analysis (2020-2032)
7.2.2 Blood Glucose Monitoring Systems Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.3 Self-monitoring Blood Glucose Systems
7.2.3.1 Self-monitoring Blood Glucose Systems Market Trends Analysis (2020-2032)
7.2.3.2 Self-monitoring Blood Glucose Systems Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.4 Continuous Glucose Monitoring Systems
7.2.4.1 Continuous Glucose Monitoring Systems Market Trends Analysis (2020-2032)
7.2.4.2 Continuous Glucose Monitoring Systems Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Cardiac Monitoring Devices
7.3.1 Cardiac Monitoring Devices Market Trends Analysis (2020-2032)
7.3.2 Cardiac Monitoring Devices Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4 Multi-parameter Monitoring Devices
7.4.1 Multi-parameter Monitoring Devices Market Trends Analysis (2020-2032)
7.4.2 Multi-parameter Monitoring Devices Market Size Estimates and Forecasts to 2032 (USD Billion)
7.5 Respiratory Monitoring Devices
7.5.1 Respiratory Monitoring Devices Market Trends Analysis (2020-2032)
7.5.2 Respiratory Monitoring Devices Market Size Estimates and Forecasts to 2032 (USD Billion)
7.6 Temperature Monitoring Devices
7.6.1 Temperature Monitoring Devices Market Trends Analysis (2020-2032)
7.6.2 Temperature Monitoring Devices Market Size Estimates and Forecasts to 2032 (USD Billion)
7.7 Hemodynamic/Pressure Monitoring Devices
7.7.1 Hemodynamic/Pressure Monitoring Devices Market Trends Analysis (2020-2032)
7.7.2 Hemodynamic/Pressure Monitoring Devices Market Size Estimates and Forecasts to 2032 (USD Billion)
7.8 Fetal & Neonatal Monitoring Devices
7.8.1 Fetal & Neonatal Monitoring Devices Market Trends Analysis (2020-2032)
7.8.2 Fetal & Neonatal Monitoring Devices Market Size Estimates and Forecasts to 2032 (USD Billion)
7.9 Weight Monitoring Devices
7.9.1 Weight Monitoring Devices Market Trends Analysis (2020-2032)
7.9.2 Weight Monitoring Devices Market Size Estimates and Forecasts to 2032 (USD Billion)
7.10 Other Patient Monitoring Devices
7.10.1 Other Patient Monitoring Devices Market Trends Analysis (2020-2032)
7.10.2 Other Patient Monitoring Devices Market Size Estimates and Forecasts to 2032 (USD Billion)
8. Patient Monitoring Devices Market Segmentation, by End Use
8.1 Chapter Overview
8.2 Hospitals
8.2.1 Hospitals Market Trends Analysis (2020-2032)
8.2.2 Hospitals Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3 Ambulatory Surgery Centers
8.3.1 Ambulatory Surgery Centers Market Trends Analysis (2020-2032)
8.3.2 Ambulatory Surgery Centers Market Size Estimates and Forecasts to 2032 (USD Billion)
8.4 Home Care Settings
8.4.1 Home Care Settings Market Trends Analysis (2020-2032)
8.4.2 Home Care Settings Market Size Estimates and Forecasts to 2032 (USD Billion)
8.4 Other
8.4.1 Other Market Trends Analysis (2020-2032)
8.4.2 Other Market Size Estimates and Forecasts to 2032 (USD Billion)
9. Regional Analysis
9.1 Chapter Overview
9.2 North America
9.2.1 Trends Analysis
9.2.2 North America Patient Monitoring Devices Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.2.3 North America Patient Monitoring Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.2.4 North America Patient Monitoring Devices Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.2.5 USA
9.2.5.1 USA Patient Monitoring Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.2.5.2 USA Patient Monitoring Devices Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.2.6 Canada
9.2.6.1 Canada Patient Monitoring Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.2.6.2 Canada Patient Monitoring Devices Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.2.7 Mexico
9.2.7.1 Mexico Patient Monitoring Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.2.7.2 Mexico Patient Monitoring Devices Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.3 Europe
9.3.1 Eastern Europe
9.3.1.1 Trends Analysis
9.3.1.2 Eastern Europe Patient Monitoring Devices Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.3.1.3 Eastern Europe Patient Monitoring Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.1.4 Eastern Europe Patient Monitoring Devices Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.3.1.5 Poland
9.3.1.5.1 Poland Patient Monitoring Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.1.5.2 Poland Patient Monitoring Devices Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.3.1.6 Romania
9.3.1.6.1 Romania Patient Monitoring Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.1.6.2 Romania Patient Monitoring Devices Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.3.1.7 Hungary
9.3.1.7.1 Hungary Patient Monitoring Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.1.7.2 Hungary Patient Monitoring Devices Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.3.1.8 Turkey
9.3.1.8.1 Turkey Patient Monitoring Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.1.8.2 Turkey Patient Monitoring Devices Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.3.1.9 Rest of Eastern Europe
9.3.1.9.1 Rest of Eastern Europe Patient Monitoring Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.1.9.2 Rest of Eastern Europe Patient Monitoring Devices Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.3.2 Western Europe
9.3.2.1 Trends Analysis
9.3.2.2 Western Europe Patient Monitoring Devices Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.3.2.3 Western Europe Patient Monitoring Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.2.4 Western Europe Patient Monitoring Devices Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.3.2.5 Germany
9.3.2.5.1 Germany Patient Monitoring Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.2.5.2 Germany Patient Monitoring Devices Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.3.2.6 France
9.3.2.6.1 France Patient Monitoring Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.2.6.2 France Patient Monitoring Devices Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.3.2.7 UK
9.3.2.7.1 UK Patient Monitoring Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.2.7.2 UK Patient Monitoring Devices Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.3.2.8 Italy
9.3.2.8.1 Italy Patient Monitoring Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.2.8.2 Italy Patient Monitoring Devices Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.3.2.9 Spain
9.3.2.9.1 Spain Patient Monitoring Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.2.9.2 Spain Patient Monitoring Devices Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.3.2.10 Netherlands
9.3.2.10.1 Netherlands Patient Monitoring Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.2.10.2 Netherlands Patient Monitoring Devices Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.3.2.11 Switzerland
9.3.2.11.1 Switzerland Patient Monitoring Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.2.11.2 Switzerland Patient Monitoring Devices Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.3.2.12 Austria
9.3.2.12.1 Austria Patient Monitoring Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.2.12.2 Austria Patient Monitoring Devices Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.3.2.13 Rest of Western Europe
9.3.2.13.1 Rest of Western Europe Patient Monitoring Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.2.13.2 Rest of Western Europe Patient Monitoring Devices Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.4 Asia Pacific
9.4.1 Trends Analysis
9.4.2 Asia Pacific Patient Monitoring Devices Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.4.3 Asia Pacific Patient Monitoring Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.4.4 Asia Pacific Patient Monitoring Devices Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.4.5 China
9.4.5.1 China Patient Monitoring Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.4.5.2 China Patient Monitoring Devices Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.4.6 India
9.4.5.1 India Patient Monitoring Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.4.5.2 India Patient Monitoring Devices Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.4.5 Japan
9.4.5.1 Japan Patient Monitoring Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.4.5.2 Japan Patient Monitoring Devices Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.4.6 South Korea
9.4.6.1 South Korea Patient Monitoring Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.4.6.2 South Korea Patient Monitoring Devices Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.4.7 Vietnam
9.4.7.1 Vietnam Patient Monitoring Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.2.7.2 Vietnam Patient Monitoring Devices Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.4.8 Singapore
9.4.8.1 Singapore Patient Monitoring Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.4.8.2 Singapore Patient Monitoring Devices Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.4.9 Australia
9.4.9.1 Australia Patient Monitoring Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.4.9.2 Australia Patient Monitoring Devices Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.4.10 Rest of Asia Pacific
9.4.10.1 Rest of Asia Pacific Patient Monitoring Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.4.10.2 Rest of Asia Pacific Patient Monitoring Devices Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.5 Middle East and Africa
9.5.1 Middle East
9.5.1.1 Trends Analysis
9.5.1.2 Middle East Patient Monitoring Devices Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.5.1.3 Middle East Patient Monitoring Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.5.1.4 Middle East Patient Monitoring Devices Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.5.1.5 UAE
9.5.1.5.1 UAE Patient Monitoring Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.5.1.5.2 UAE Patient Monitoring Devices Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.5.1.6 Egypt
9.5.1.6.1 Egypt Patient Monitoring Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.5.1.6.2 Egypt Patient Monitoring Devices Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.5.1.7 Saudi Arabia
9.5.1.7.1 Saudi Arabia Patient Monitoring Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.5.1.7.2 Saudi Arabia Patient Monitoring Devices Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.5.1.8 Qatar
9.5.1.8.1 Qatar Patient Monitoring Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.5.1.8.2 Qatar Patient Monitoring Devices Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.5.1.9 Rest of Middle East
9.5.1.9.1 Rest of Middle East Patient Monitoring Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.5.1.9.2 Rest of Middle East Patient Monitoring Devices Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.5.2 Africa
9.5.2.1 Trends Analysis
9.5.2.2 Africa Patient Monitoring Devices Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.5.2.3 Africa Patient Monitoring Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.5.2.4 Africa Patient Monitoring Devices Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.5.2.5 South Africa
9.5.2.5.1 South Africa Patient Monitoring Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.5.2.5.2 South Africa Patient Monitoring Devices Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.5.2.6 Nigeria
9.5.2.6.1 Nigeria Patient Monitoring Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.5.2.6.2 Nigeria Patient Monitoring Devices Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.5.2.7 Rest of Africa
9.5.2.7.1 Rest of Africa Patient Monitoring Devices Market Estimates and Forecasts, by Component (2020-2032) (USD Billion)
9.5.2.7.2 Rest of Africa Patient Monitoring Devices Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.6 Latin America
9.6.1 Trends Analysis
9.6.2 Latin America Patient Monitoring Devices Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.6.3 Latin America Patient Monitoring Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.6.4 Latin America Patient Monitoring Devices Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.6.5 Brazil
9.6.5.1 Brazil Patient Monitoring Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.6.5.2 Brazil Patient Monitoring Devices Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.6.6 Argentina
9.6.6.1 Argentina Patient Monitoring Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.6.6.2 Argentina Patient Monitoring Devices Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.6.7 Colombia
9.6.7.1 Colombia Patient Monitoring Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.6.7.2 Colombia Patient Monitoring Devices Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
9.6.8 Rest of Latin America
9.6.8.1 Rest of Latin America Patient Monitoring Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.6.8.2 Rest of Latin America Patient Monitoring Devices Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
10. Company Profiles
10.1 Smiths Medical
10.1.1 Company Overview
10.1.2 Financial
10.1.3 Products/ Services Offered
110.1.4 SWOT Analysis
10.2 Biotronik
10.2.1 Company Overview
10.2.2 Financial
10.2.3 Products/ Services Offered
10.2.4 SWOT Analysis
10.3 Mindray Medical International Ltd.
10.3.1 Company Overview
10.3.2 Financial
10.3.3 Products/ Services Offered
10.3.4 SWOT Analysis
10.4 Koninklijke Philips N.V.
10.4.1 Company Overview
10.4.2 Financial
10.4.3 Products/ Services Offered
10.4.4 SWOT Analysis
10.5 Nihon Kohden
10.5.1 Company Overview
10.5.2 Financial
10.5.3 Products/ Services Offered
10.5.4 SWOT Analysis
10.6 Welch Allyn
10.6.1 Company Overview
10.6.2 Financial
10.6.3 Products/ Services Offered
10.6.4 SWOT Analysis
10.7 Health anywhere Inc.
10.7.1 Company Overview
10.7.2 Financial
10.7.3 Products/ Services Offered
10.7.4 SWOT Analysis
10.8 Intel
10.8.1 Company Overview
10.8.2 Financial
10.8.3 Products/ Services Offered
10.8.4 SWOT Analysis
10.9 GE Healthcare
10.9.1 Company Overview
10.9.2 Financial
10.9.3 Products/ Services Offered
10.9.4 SWOT Analysis
10.10 Medtronic
10.9.1 Company Overview
10.9.2 Financial
10.9.3 Products/ Services Offered
10.9.4 SWOT Analysis
11. Use Cases and Best Practices
12. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
Key Segments:
By Product
Blood Glucose Monitoring Systems
Self-monitoring Blood Glucose Systems
Continuous Glucose Monitoring Systems
Cardiac Monitoring Devices
ECG Devices
Implantable Loop Recorders
Event Monitors
Mobile Cardiac Telemetry Monitors
Smart/Wearable ECG Monitors
Multi-parameter Monitoring Devices.
Low-acuity Monitoring Devices
Mid-acuity Monitoring Devices
High-acuity Monitoring Devices
Respiratory Monitoring Devices
Pulse Oximeters
Spirometers
Capnographs
Peak Flow Meters
Temperature Monitoring Devices
Handheld Temperature Monitoring Devices
Table-top Temperature Monitoring Devices
Wearable Continuous Monitoring Devices
Invasive Temperature Monitoring Devices
Smart Temperature Monitoring Devices
Hemodynamic/Pressure Monitoring Devices
Hemodynamic Monitors
Blood Pressure Monitors
Disposables
Fetal & Neonatal Monitoring Devices
Fetal Monitoring Devices
Neonatal Monitoring Devices
Neuromonitoring Devices
Electroencephalograph Machines
Electromyography Machines
Cerebral Oximeters
Intracranial Pressure Monitors
Magnetoencephalograph Machines
Transcranial Doppler Machines
Weight Monitoring Devices
Digital
Analog
Other Patient Monitoring Devices
By End-use
Hospitals
Ambulatory Surgery Centers
Home Care Settings
Other
Request for Segment Customization as per your Business Requirement: Segment Customization Request
REGIONAL COVERAGE:
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of the Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Product Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Product Matrix which gives a detailed comparison of product portfolio of each company
Geographic Analysis
Additional countries in any of the regions
Company Information
Detailed analysis and profiling of additional market players (Up to five)
The Medical Carts Market Size was valued at USD 3.08 billion in 2023 and is expected to reach USD 12.56 billion by 2032 and grow at a CAGR of 16.88% over the forecast period 2024-2032.
The Neuroprosthetics Market size was valued at USD 11.71 billion in 2023 and is expected to reach at USD 30.26 billion by 2031 and grow at a CAGR of 12.6% over the forecast period of 2024-2031.
The Antiepileptic Drugs Market size was estimated at USD 18.21 billion in 2023 and is expected to reach USD 26.30 billion by 2031 at a CAGR of 4.70% during the forecast period of 2024-2031.
The Disposable Medical Gloves Market was valued at USD 9.15 Bn in 2023 and is expected to reach USD 29.17 Bn by 2031 and grow at a CAGR of 15.6% during the forecasted period 2024-2031.
The Prescription Drugs Market size was valued at USD 1162.60 Billion In 2023 & is estimated to reach USD 2173.61 Billion by 2032 and increase at a CAGR of 7.2% between 2024 and 2032.
The Blood Pressure Monitors Market was valued at USD 2.25 Bn in 2023 and is estimated to reach USD 3.90 Bn by 2032 with a growing CAGR of 6.3% over the forecast period of 2024-2032.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
